| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00002030-200402200-00023 |
| P698 | PubMed publication ID | 15090809 |
| P50 | author | Charles F. Gilks | Q58302660 |
| Neil French | Q61783828 | ||
| P2093 | author name string | Martin Dedicoat | |
| Kate Grimwade | |||
| Daniel D Mbatha | |||
| Dawn D Zungu | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | South Africa | Q258 |
| Plasmodium falciparum | Q311383 | ||
| HIV transmission | Q49029021 | ||
| malaria transmission | Q56928847 | ||
| P304 | page(s) | 547-554 | |
| P577 | publication date | 2004-02-01 | |
| P1433 | published in | AIDS | Q4651863 |
| P1476 | title | HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa | |
| P478 | volume | 18 |
| Q41924572 | A Study of Malaria Parasite Density in HIV-1 Positive Under-fives in Benin City, Nigeria |
| Q36309128 | A cross-sectional study of sub-clinical Plasmodium falciparum infection in HIV-1 infected and uninfected populations in Mozambique, South-Eastern Africa |
| Q30424362 | Antimalaria action of antiretroviral drugs on Plasmodium berghei in mice |
| Q42910139 | Antimalarial asexual stage-specific and gametocytocidal activities of HIV protease inhibitors |
| Q35004887 | Antimalarial effects of human immunodeficiency virus protease inhibitors in rhesus macaques |
| Q24235145 | Artemisinin-based combination therapy for uncomplicated P. falciparum malaria in children with HIV |
| Q26471338 | Artemisinin-based combination therapy for uncomplicatedP. falciparummalaria in children with HIV |
| Q38155450 | Clinical pharmacokinetic drug interactions associated with artemisinin derivatives and HIV-antivirals. |
| Q36624183 | Co-infection of malaria with HIV: an immunological perspective |
| Q36931785 | Community-wide Prevalence of Malaria Parasitemia in HIV-Infected and Uninfected Populations in a High-Transmission Setting in Uganda |
| Q37893776 | Consequences of HIV infection on malaria and therapeutic implications: a systematic review |
| Q36418338 | Correlates of HIV and malaria co-infection in Southern India |
| Q43947376 | Cross-sectional relationship between HIV, lymphatic filariasis and other parasitic infections in adults in coastal northeastern Tanzania |
| Q33762223 | Decrease in Numbers of Naive and Resting B Cells in HIV-Infected Kenyan Adults Leads to a Proportional Increase in Total and Plasmodium falciparum-Specific Atypical Memory B Cells |
| Q38456034 | Developing an evidence-based, preventive care package for persons with HIV in Africa |
| Q36249062 | Diagnosis, clinical presentation, and in-hospital mortality of severe malaria in HIV-coinfected children and adults in Mozambique |
| Q24810617 | Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa |
| Q38879589 | Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study |
| Q40144262 | Effect of cotrimoxazole prophylaxis on malaria occurrence among HIV-infected adults in West Africa: the MALHIV Study |
| Q28084902 | Effect of cotrimoxazole prophylaxis on malaria occurrence in HIV-infected patients on antiretroviral therapy in sub-Saharan Africa |
| Q33439223 | Effect of malaria infection on hematological profiles of people living with human immunodeficiency virus in Gambella, southwest Ethiopia |
| Q43795095 | Enhanced T cell activation in Plasmodium falciparum malaria-infected human immunodeficiency virus-1 patients from Mozambique |
| Q51779052 | Epidemic malaria and warmer temperatures in recent decades in an East African highland |
| Q36431951 | Estimated financial and human resources requirements for the treatment of malaria in Malawi |
| Q35272841 | Evaluation of a PfHRP-2 based rapid diagnostic test versus microscopy method among HIV-positive and unknown serology patients in Ouagadougou, Burkina Faso |
| Q40603559 | Evaluation of some haemostatic parameters in falciparum malaria and HIV co-infection |
| Q35531240 | Evidence for an increased risk of transmission of simian immunodeficiency virus and malaria in a rhesus macaque coinfection model |
| Q40100338 | Factors associated with severe malaria among children below ten years in Mutasa and Nyanga districts, Zimbabwe, 2014-2015. |
| Q37041441 | Falciparum malaria and HIV-1 in hospitalized adults in Maputo, Mozambique: does HIV-infection obscure the malaria diagnosis? |
| Q36177513 | Fatal Pediatric Cerebral Malaria Is Associated with Intravascular Monocytes and Platelets That Are Increased with HIV Coinfection |
| Q30388860 | HIV Malaria Co-Infection Is Associated with Atypical Memory B Cell Expansion and a Reduced Antibody Response to a Broad Array of Plasmodium falciparum Antigens in Rwandan Adults |
| Q35012924 | HIV Protease Inhibitors: Effect on the Opportunistic Protozoan Parasites |
| Q56793045 | HIV and Malaria: An Immunologic Perspective |
| Q40106098 | HIV-malaria interactions in North-East India: A prospective cohort study |
| Q34983798 | Hematological predictors of increased severe anemia in Kenyan children coinfected with Plasmodium falciparum and HIV-1. |
| Q37686622 | Host immunity as a determinant of treatment outcome in Plasmodium falciparum malaria |
| Q36919663 | Human immunodeficiency virus (HIV) and malaria interaction in sub-Saharan Africa: the collision of two Titans |
| Q33793608 | Human immunodeficiency virus infection and cerebral malaria in children in Uganda: a case-control study |
| Q37123511 | Immune activation and regulation in simian immunodeficiency virus-Plasmodium fragile-coinfected rhesus macaques |
| Q41937928 | Impact of delayed introduction of sulfadoxine-pyrimethamine and arthemeter-lumefantrine on malaria epidemiology in KwaZulu-Natal, South Africa |
| Q46977081 | Increased prevalence of severe malaria in HIV-infected adults in South Africa |
| Q37203716 | Increased risk for severe malaria in HIV-1-infected adults, Zambia |
| Q38695833 | Inhibition of Plasmodium Hepatic Infection by Antiretroviral Compounds |
| Q34404275 | Interactions between malaria and human immunodeficiency virus anno 2014 |
| Q44148483 | KIR3DL1/S1 genotypes and KIR2DS4 allelic variants in the AB KIR genotypes are associated with Plasmodium-positive individuals in malaria infection |
| Q36033898 | Malaria and hiv in adults: when the parasite runs into the virus |
| Q21032444 | Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa |
| Q44143537 | Malaria drug resistance: the impact of human movement and spatial heterogeneity |
| Q51875352 | NeuroAIDS in the Asia Pacific Region. |
| Q33999657 | No evidence of association between HIV-1 and malaria in populations with low HIV-1 prevalence |
| Q35494337 | Occupational activities associated with a reported history of malaria among women working in small-scale agriculture in South Africa |
| Q28727971 | P. falciparum enhances HIV replication in an experimental malaria challenge system |
| Q38213994 | Parasite virulence, co-infections and cytokine balance in malaria |
| Q36328956 | Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis |
| Q33692808 | Pharmacokinetic interactions between ritonavir and quinine in healthy volunteers following concurrent administration |
| Q54212174 | Pharmacokinetics and safety profile of artesunate-amodiaquine co-administered with antiretroviral therapy in malaria uninfected HIV-positive Malawian adults. |
| Q56355681 | Pharmacokinetics of Piperaquine and Safety Profile of Dihydroartemisinin-Piperaquine Coadministered with Antiretroviral Therapy in Malaria-Uninfected HIV-Positive Malawian Adults |
| Q36161252 | Pharmacotherapy, vaccines and malaria advice for HIV-infected travellers |
| Q92819435 | Plasma levels of interleukin 27 in falciparum malaria is increased independently of co-infection with HIV: potential immune-regulatory role during malaria |
| Q33817605 | Plasmodium falciparum dihydrofolate reductase and dihyropteroate synthase mutations and the use of trimethoprim-sulfamethoxazole prophylaxis among persons infected with human immunodeficiency virus |
| Q38983145 | Plasmodium knowlesi and HIV co-infection in a German traveller to Thailand |
| Q43591754 | Polyuria in association with Plasmodium falciparum malaria in a region of unstable transmission |
| Q36406927 | Practical Management of HIV-Associated Anemia in Resource-Limited Settings: Prospective Observational Evaluation of a New Mozambican Guideline |
| Q89733528 | Predictors of outcome in childhood Plasmodium falciparum malaria |
| Q35656242 | Presence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected Population |
| Q35938053 | Providing insecticide treated bed nets in antiretroviral treatment clinics in Malawi: a pilot study. |
| Q33264847 | Putting it together: AIDS and the millennium development goals |
| Q36378338 | Regulating immunity to malaria |
| Q36556133 | Simulation of malaria epidemiology and control in the highlands of Western Kenya |
| Q34611339 | Supplementation with multivitamins and vitamin A and incidence of malaria among HIV-infected Tanzanian women |
| Q36052615 | T-cell depletion and immunity to malaria in HIV-infections |
| Q37206613 | The Effect of Malaria and HIV Co-Infection on Anemia: A Meta-Analysis |
| Q35912396 | The Impact of HIV Coinfection on Cerebral Malaria Pathogenesis. |
| Q37297061 | The Impact of HIV and Malaria Coinfection: What Is Known and Suggested Venues for Further Study |
| Q40793767 | The Implications of HIV Treatment on the HIV-Malaria Coinfection Dynamics: A Modeling Perspective |
| Q46594461 | The Interaction between HIV and malaria in Africa |
| Q36504556 | The effect of HIV on malaria in the context of the current standard of care for HIV-infected populations in Africa |
| Q36319202 | The effect of HIV on morbidity and mortality in children with severe malarial anaemia |
| Q38880540 | The effect of malaria on mortality in a cohort of HIV-infected Ugandan adults |
| Q36072558 | The immuno-epidemiology of pregnancy-associated Plasmodium falciparum malaria: a variant surface antigen-specific perspective |
| Q36840133 | The impact of HIV-1 on the malaria parasite biomass in adults in sub-Saharan Africa contributes to the emergence of antimalarial drug resistance |
| Q33692424 | The influence of the Gilgel-Gibe hydroelectric dam in Ethiopia on caregivers' knowledge, perceptions and health-seeking behaviour towards childhood malaria |
| Q35164569 | The prevalence of malaria among HIV seropositive individuals and the impact of the co- infection on their hemoglobin levels |
| Q36130329 | The prevalence of malaria in people living with HIV in Yaounde, Cameroon |
| Q35149893 | The role of coinfections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis |
| Q36723819 | Treatment of childhood Plasmodium falciparum malaria: current challenges |
| Q35557138 | Virus infection stages and distinct Th1 or Th17/Th22 T-cell responses in malaria/SHIV coinfection correlate with different outcomes of disease |
Search more.